MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT05508763 | ACTIVE_NOT_RECRUITING
2000 participants

Personalised Therapeutics @LUMC

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-02
Start Date:
2022-12-01
Completion:
2026-09-30
Conditions
  • Adverse Drug Reaction
Interventions
  • GENETIC
No Results Yet
NCT05476926 | ACTIVE_NOT_RECRUITING
6000 participants

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-02
Start Date:
2022-11-21
Completion:
2026-11-30
Conditions
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Retinal Vein Occlusion
  • Branch Retinal Vein Occlusion
  • Central Retinal Vein Occlusion
  • Hemi-retinal Vein Occlusion
Interventions
  • DRUG
  • COMBINATION_PRODUCT
No Results Yet
NCT05334069 | RECRUITING
2000 participants

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-02
Start Date:
2022-08-18
Completion:
2027-01-31
Conditions
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Ann Arbor Stage I Lymphoma
  • Ann Arbor Stage II Lymphoma
  • Ann Arbor Stage III Lymphoma
  • Ann Arbor Stage IV Lymphoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • Gastroesophageal Junction Adenocarcinoma
  • Head and Neck Carcinoma
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Invasive Breast Carcinoma
  • Kidney Carcinoma
  • Malignant Hepatobiliary Neoplasm
  • Malignant Solid Neoplasm
  • Melanoma
  • Muscle-Invasive Bladder Carcinoma
  • RISS Stage I Plasma Cell Myeloma
  • RISS Stage II Plasma Cell Myeloma
  • RISS Stage III Plasma Cell Myeloma
  • Sarcoma
  • Stage I Bladder Cancer AJCC v6 and v7
  • Stage I Breast Cancer AJCC v7
  • Stage I Colorectal Cancer AJCC v6 and v7
  • Stage I Esophageal Cancer AJCC V7
  • Stage I Gastric Cancer AJCC V7
  • Stage I Lung Cancer AJCC v7
  • Stage I Ovarian Cancer AJCC v6 and v7
  • Stage I Pancreatic Cancer AJCC v6 and v7
  • Stage I Prostate Cancer AJCC v7
  • Stage I Uterine Corpus Cancer AJCC v7
  • Stage II Bladder Cancer AJCC v6 and v7
  • Stage II Breast Cancer AJCC v6 and v7
  • Stage II Colorectal Cancer AJCC v7
  • Stage II Esophageal Cancer AJCC v7
  • Stage II Gastric Cancer AJCC v7
  • Stage II Lung Cancer AJCC v7
  • Stage II Ovarian Cancer AJCC v6 and v7
  • Stage II Pancreatic Cancer AJCC v6 and v7
  • Stage II Prostate Cancer AJCC v7
  • Stage II Uterine Corpus Cancer AJCC v7
  • Stage III Bladder Cancer AJCC v6 and v7
  • Stage III Breast Cancer AJCC v7
  • Stage III Colorectal Cancer AJCC v7
  • Stage III Esophageal Cancer AJCC v7
  • Stage III Gastric Cancer AJCC v7
  • Stage III Lung Cancer AJCC v7
  • Stage III Ovarian Cancer AJCC v6 and v7
  • Stage III Pancreatic Cancer AJCC v6 and v7
  • Stage III Prostate Cancer AJCC v7
  • Stage III Uterine Corpus Cancer AJCC v7
  • Stage IV Bladder Cancer AJCC v7
  • Stage IV Breast Cancer AJCC v6 and v7
  • Stage IV Colorectal Cancer AJCC v7
  • Stage IV Esophageal Cancer AJCC v7
  • Stage IV Gastric Cancer AJCC v7
  • Stage IV Lung Cancer AJCC v7
  • Stage IV Ovarian Cancer AJCC v6 and v7
  • Stage IV Pancreatic Cancer AJCC v6 and v7
  • Stage IV Prostate Cancer AJCC v7
  • Stage IV Uterine Corpus Cancer AJCC v7
  • Thyroid Gland Carcinoma
Interventions
  • OTHER
  • PROCEDURE
No Results Yet
NCT05319730 | RECRUITING | PHASE1/PHASE2
230 participants

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2023-05-16
Completion:
2027-06-11
Conditions
  • Esophageal Squamous Cell Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT05286814 | RECRUITING | PHASE2
70 participants

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2022-10-24
Completion:
2027-12-31
Conditions
  • Metastatic Colorectal Cancer (Mcrc)
  • Intrahepatic Cholangiocarcinoma (Icc)
  • Intrahepatic Bile Duct Cancer
  • Colorectal Neoplasms
  • Colorectal Cancer
  • Cholangiocarcinoma
  • Bile Duct Neoplasms
  • Bile Duct Cancer
  • Adrenocortical Carcinoma (ACC)
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adrenal Gland Neoplasms
  • Adrenal Cortex Neoplasms
Interventions
  • DRUG
  • DEVICE
No Results Yet
NCT05245500 | RECRUITING | PHASE1
336 participants

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2022-06-09
Completion:
2027-12-10
Conditions
  • Mesothelioma
  • Non Small Cell Lung Cancer
  • Malignant Peripheral Nerve Sheath Tumors
  • Solid Tumor
  • Pancreatic Adenocarcinoma
  • Advanced Solid Tumor
Interventions
  • DRUG
No Results Yet
NCT05224154 | COMPLETED | NA
9 participants

Re-Connect Application for Smoking Cessation

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2021-12-14
Completion:
2026-02-28
Conditions
  • Smoking Cessation
  • Acceptability of Health Care
  • Nicotine Dependence, Cigarettes
Interventions
  • BEHAVIORAL
No Results Yet
NCT05028309 | RECRUITING | NA
72 participants

Effects of Obesity in the Aged

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-02
Start Date:
2021-12-01
Completion:
2026-12-31
Conditions
  • Obesity
  • Aging
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page